Polaryx Therapeutics

Rare disease biotech Polaryx Therapeutics files for a direct listing on the Nasdaq   February 2, 2026 News Micro-cap Polaryx Therapeutics to trade on the Nasdaq today via direct listing Polaryx Therapeutics, a Phase 2-ready biotech developing oral formulations of... Read more